0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C

Michiko Shindo, MD, PhD; Adrian M. Di Bisceglie, MD; Ling Cheung, BA; J. Wai-Kuo Shih, PhD; Karen Cristiano, PhD; Stephen M. Feinstone, MD; and Jay H. Hoofnagle, MD
[+] Article and Author Information

Requests for Reprints: Michiko Shindo, MD, PhD, Liver Diseases Section, Building 10, Room 4D52, National Institutes of Health, Bethesda, MD 20892.

Current Author Addresses: Drs. Shindo, Di Bisceglie, and Hoofnagle: Liver Diseases Section, Building 10, Room 4D52, National Institutes of Health, Bethesda, MD 20892.

Ms. Cheung and Dr. Shih: Department of Transfusion Transmitted Virus Research, Building 10, Room ID46, National Institutes of Health, Bethesda, MD 20892.

Drs. Cristiano and Feinstone: Center for Biologic Evaluation and Research, Hepatitis Research Laboratory, Food and Drug Administration, Rockville, MD 20895.


Ann Intern Med. 1991;115(9):700-704. doi:10.7326/0003-4819-115-9-700
Text Size: A A A

Objective: To assess the effect of alpha-interferon therapy on hepatitis C viral RNA in serum of patients with chronic hepatitis C.

Design: Retrospective testing for hepatitis C viral (HCV) RNA and antibody to the hepatitis C virus (anti-HCV) of stored serum samples from a randomized, double-blind, placebo-controlled trial of alphainterferon therapy.

Setting: Warren Grant Magnuson Clinical Center of the National Institutes of Health, a tertiary referral center.

Patients: Forty-one patients with chronic non-A, non-B hepatitis were entered in this trial.

Interventions: Twenty-one patients were treated with alpha-interferon, and 20 patients were treated with placebo for 6 months. Seventeen placebo recipients were then treated with alpha-interferon for up to 1 year.

Methods: Samples were tested for anti-HCV by enzyme-linked immunosorbent assay. Hepatitis C viral RNA was detected in serum using the polymerase chain reaction. Titers of both antibody and RNA were determined by serial end-point dilution.

Main Results: At entry into the trial, 37 (90%) of 41 patients had anti-HCV and 39 (95%) had HCV RNA in serum. Anti-HCV titers decreased slightly with treatment. Serum levels of HCV RNA decreased in all patients who responded to alpha-interferon therapy with improvements in serum aminotransferases; in 17 of 21 responders (81%; 95% Cl, 58% to 95%) HCV RNA became undetectable. In contrast, in only 2 of 16 (12%; Cl, 2% to 38%) patients who did not respond to treatment did HCV RNA become undetectable. In 19 patients treated during the preliminary 6-month period with placebo, HCV RNA remained detectable. Finally, in the 11 patients who relapsed when treatment was stopped, HCV RNA reappeared in the serum, but in 4 of 7 patients with a sustained improvement in serum aminotransferases, HCV RNA remained undetectable.

Conclusions: These results indicate that the clinical and serum biochemical response to alpha-interferon in chronic hepatitis C is associated with a loss of detectable HCV genome from serum.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Journal Club
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)